页数:12页文件大小:455.0 KB来源: 药理学ppt课件
本课件为药理学课程中的《治疗充血性心衰药》,围绕治疗充血性心衰药、治疗充血性心衰药 Drugs、Heart failure、K+3Na+等部分展开,逐页梳理概念、机制与临床应用要点,适合预习、课堂对照与考前复习。
治疗充血性心衰药 Drugs used in heart failure
Myocardial remodeling in Calcineurin transgenic hearts(Cell, Vol 93, 215-228,1998)
Heart failure Reduced cardiac output Sympathetic nervoussystem activation Vasoconstriction Elevated cardiacfilling pressure Sodium and waterretention AngiotensinⅠRenin Cardiac remodeling Aldosterone AngiotensinⅡPathophysiological mechanisms of heart failure and major sites of drug actiondigoxinβ-blockers, digoxin Vasodilators ACE inhibitors Spironolactone Diuretics Angiotensin-R blockers
Structure of digoxin, a typical cardiac glycoside
K+3Na+2K+Na+3Na+Ca2+Ca2+Ca2+SRCardiac glycosides Regulation of intracellular [Ca]2+iandthe action of cardiac glycosides
Effects of a cardiac glycoside, Ouabain,on isolated cardiac tissue( from Basic and clinical pharmacology, 8th2001)
Signs and symptoms of cardiac glycoside toxicity Psychiatric Delirium, fatigue, confusion, dizziness,abnormal dreams Visual Blurred or yellow vision, halos Gastrointestinal Nausea, vomiting,abdominal pain Cardiac arrhythmias Atrial and ventricular ectopic arrhythmias Conduction disturbances Sinoatrial and atrioventricular nodeconduction disturbances
Effect of spironolactone on survival in patients with moderate or severecongestive heart failure in a randomized double-blind clinical study.(from Basic and clinical pharmacology, 8th2001)
Drugclass Examples Mechanismofvasodilatingaction Preloadreduction Afterloadreduction Organicnitrates Nitroglycerin Nitricoxide-mediatedvasodilation++++Nitricoxidedonors Nitroprusside Nitricoxide-mediatedvasodilation++++++ACEinhibitors Captopril Inhibitionofangiotensingeneration++++Angiotensinreceptorblockers Iosartan Blockadeofangiotensinreceptors++++Phosphodiesteraseinhibitors Milrinone Inhibitionofc AMPdegradation++++Direct-acting Hydralazine Unknown++++α1-receptorantagonists Prazosin Selectiveα1-receptorblockade+++++Nonselectiveα-receptorantagonists Phemtolamine Nonselectiveα-receptorblockade++++++Ca2+channelblockers Nifedipine Inhibitionof L-type Ca2+channels++++β-receptoragonists Isoproterenol Stimulationofvascularβ2-receptors+++Vasodilator drugs used to treat heart failure
Major effects of angiotensin II and the mechanism thatmediate them Angiotensin IIAltered peripheralresistance Altered cardiovascularstructure Altered renalfunction A. Direct vasoconstriction. B. Enhancement ofperipheral noradrenergicneurotransmission. C. Increased sympatheticdischarge. D. Release of catechola-mines from adrenalmedulla. A. Direct effect to increase Na+reabsorption inproximal tubule. B. Release of aldosteronefrom adrenal cortex. C. Altered renal hemo-dynamics. A. Increased expression ofproto-oncogence. B. Increased production ofgrowth factors. C. Increased synthesis ofextracellular matrixproteins. D. Increased afterload. E. Increased wall tension.
renin Angiotensinogen Angiotensin IOther pathways Angiotensin IIReceptors AT1AT2Vasoconstriction Proliferative Action Vasodilatation Antiproliferative Action ACE
1. Reduce workload of the hearta. Limit activity levelb. Reduce weightc. Control hypertension2. Restrict sodium3. Give diuretics4. Give ACE inhibitor and digitalis5. Give β-blockers to patients withstable class Ⅱ-Ⅲ heart failure6. Give vasodilators Steps in the treatment of chronic heart failure
下载地址:{{downurl}}
{{{a}}}
{{#b}}{{{b}}}
{{/b}} {{/title}} {{#nolog}}登陆注册
{{/nolog}} {{#djsx}}点我刷新
{{/djsx}} {{#gocz}} {{/gocz}} {{#ffqr}} {{/ffqr}}